Please ensure Javascript is enabled for purposes of website accessibility
Trump Administration Halts HIV Drug Distribution in Poor Countries
d8a347b41db1ddee634e2d67d08798c102ef09ac
By The New York Times
Published 7 months ago on
January 28, 2025

The Trump administration's freeze on foreign aid has halted HIV medication disbursements, leaving patients without treatment and threatening lives, while PEPFAR's future remains uncertain. (AP File)

Share

Getting your Trinity Audio player ready...

The Trump administration has instructed organizations in other countries to stop disbursing HIV medications purchased with U.S. aid, even if the drugs have already been obtained and are sitting in local clinics.

The directive is part of a broader freeze on foreign aid initiated last week. It includes the President’s Emergency Plan for AIDS Relief, the global health program started by George W. Bush that is credited with saving more than 25 million lives worldwide.

The administration had already moved to stop PEPFAR funding from moving to clinics, hospitals and other organizations in low-income countries.

Appointments are being canceled, and patients are being turned away from clinics, according to people with knowledge of the situation who feared retribution if they spoke publicly. Many people with HIV are facing abrupt interruptions to their treatment.

But most federal officials are also under strict orders not to communicate with external partners, leading to confusion and anxiety, according to several people with knowledge of the situation.

U.S. officials have also been told to stop providing technical assistance to national ministries of health.

“The partners we collaborate with are in shock, and they do not know what to do because their lifesaving mission and commitment has been breached,” said Asia Russell, executive director of the advocacy group Health Gap.

CDC Was Told to Stop Communicating With WHO

Late Sunday night, according to an email viewed by The New York Times, employees of the Centers for Disease Control and Prevention were instructed, effective immediately, to stop communicating with personnel at the World Health Organization.

They were later directed not even to be in the same meeting room — real or virtual — as WHO employees or to participate in email conversations in which WHO staff members are also engaged.

Some said they had been too afraid to contact colleagues they consider friends, even if just to say goodbye, and did not wish to be identified for fear of retribution.

On Monday afternoon, officials worldwide were alerted that PEPFAR’s data systems would shut down at 6 p.m. Eastern — roughly three hours after the email was received — immediately closing off access to all data sets, reports and analytical tools.

“Users should prioritize copying key documents and data,” said the email viewed by the Times.

The message prompted speculation that the program would not resume, as its future was already in question.

Some Republican senators have campaigned against PEPFAR’s reauthorization for five years, alleging that the program promoted abortions. In March, the program was renewed for one year.

Virus Levels in People With HIV Will Spike Without Treatment

Without treatment, virus levels in people with HIV will quickly spike, hobbling the immune systems of the infected people and increasing the odds that they will spread the virus to others.

About 1 in 3 untreated pregnant women may pass the virus onto their babies.

Interrupted treatment may also lead to the emergence of resistant strains that can spread across the world.

One study estimated that if PEPFAR were to end, as many as 600,000 lives would be lost over the next decade in South Africa alone. And that nation relies on PEPFAR for only 20% of its HIV budget. Some poorer countries are almost entirely dependent on the program.

“This is another domino in the devastating impact of the harmful freeze to programs, leaving lives hanging in the balance,” said Jirair Ratevosian, who served as chief of staff for PEPFAR during the Biden administration.

This article originally appeared in The New York Times.

By Apoorva Mandavilli
c. 2025 The New York Times Company

RELATED TOPICS:

Search

Help continue the work that gets you the news that matters most.

Send this to a friend